| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $0.69 | $0.55 | $0.44 | $0.40 | $0.79 | $1.35 | $0.54 | $0.30 |
| EPS (Diluted) | $0.69 | $0.55 | $0.44 | $0.39 | $0.78 | $1.35 | $0.54 | $0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.8B | $16.3B | $16.5B | $16.3B | $18.7B | $16.9B | $15.2B | $13.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $13.6B | $14.0B | $14.3B | $14.2B | $16.1B | $14.6B | $13.0B | $11.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.2B | $2.2B | $2.1B | $2.0B | $2.5B | $2.3B | $2.1B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.3B | $0.4B | $1.2B | $0.8B | $0.3B | $-0.4B | $0.4B |
| Investing Cash Flow | $-0.4B | $0.4B | $0.2B | $-0.9B | $-0.6B | $-0.8B | $-0.6B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $-0.2B | $-0.3B | $-1.7B | $1.5B | $1.3B | $0.9B | $0.0B |